Next Generation DX Summit 2018 | Challenges and Opportunities in Molecular Testing

Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California Dr. Jennifer Dien Bard shares her insights into what the biggest challenges and opportunities are in implementing molecular point-of-care testing for infectious disease diagnostics, and rapid genetic and phenotypic susceptibility testing. Jennifer will be speaking at Molecular Diagnostics for Infectious Disease and co-instructing a short course on Rapid Diagnostics for Antimicrobial Resistance at the Next Generation Dx Summit August 20 to 24, 2018 in Washington, DC. For more information please visit http://www.NextGenerationDX.com/Infectious-Disease-Diagnostics/ and http://www.NextGenerationDX.com/SC-6/